Rosalie Pacula

Address650 Childs Way
University Park Campus
Los Angeles CA 90089
Phone+1 213 821 8887
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Impact of Marijuana Legalization on Opioid Prescribing and Poisonings in Colorado
    NIH R01DA045051Jul 15, 2018 - Mar 31, 2021
    Role: Principal Investigator
    The RAND Alcohol Policy Platform (RAPP): A Microsimulation Model of Alcohol Use, Consequences, and Policies in the United States
    NIH R01AA022132May 15, 2014 - Apr 30, 2021
    Role: Principal Investigator
    American Society of Health Economists
    NIH R13DA037684Apr 1, 2014 - Mar 31, 2015
    Role: Co-Principal Investigator
    Implementation of Medical Marijuana and its Impact on Health
    NIH R01DA032693Sep 15, 2011 - Aug 31, 2016
    Role: Principal Investigator
    NIH R01DA019993May 10, 2006 - Apr 30, 2011
    Role: Principal Investigator
    NIH R01DA012724Feb 10, 2000 - Jul 31, 2008
    Role: Principal Investigator
    NIH F31AA005367Jan 30, 1994
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update. Int J Drug Policy. 2021 Aug 28; 103381. Fischer B, Robinson T, Bullen C, Curran V, Jutras-Aswad D, Medina-Mora ME, Pacula RL, Rehm J, Room R, Brink WVD, Hall W. PMID: 34465496.
      View in: PubMed   Mentions:    Fields:    
    2. Assessment of Recreational Cannabis Dispensaries' Compliance With Underage Access and Marketing Restrictions in California. JAMA Pediatr. 2021 Aug 16. Shi Y, Pacula RL. PMID: 34398218.
      View in: PubMed   Mentions:    Fields:    
    3. Mental Health Conditions and Substance Use Disorders Among Youth Subsequently Diagnosed With Opioid Use Disorder or Opioid Poisoning. J Addict Med. 2021 Jul 13. Agbese E, Stein BD, Druss BG, Dick AW, Pacula RL, Leslie DL. PMID: 34261890.
      View in: PubMed   Mentions:    Fields:    
    4. Commentary on Rychert and Wilkins (2021) 'Why did New Zealand's referendum to legalise recreational cannabis fail?' Drug Alcohol Rev. 2021 Sep; 40(6):884-885. Pacula RL. PMID: 34002906.
      View in: PubMed   Mentions:    Fields:    
    5. Trends in personal and family member opioid prescriptions prior to a diagnosis of an opioid-related problem among adolescents and young adults. Subst Abus. 2021 Apr 02; 1-5. Cohrs AC, Pacula RL, Dick AW, Stein BD, Druss BG, Leslie DL. PMID: 33797321.
      View in: PubMed   Mentions:    Fields:    
    6. Current U.S. State Cannabis Sales Limits Allow Large Doses for Use or Diversion. Am J Prev Med. 2021 05; 60(5):701-705. Pacula RL, Blanchette JG, Lira MC, Smart R, Naimi TS. PMID: 33589301.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    7. Internet search and medicaid prescription drug data as predictors of opioid emergency department visits. NPJ Digit Med. 2021 Feb 11; 4(1):21. Young SD, Zhang Q, Zhou J, Pacula RL. PMID: 33574500.
      View in: PubMed   Mentions:
    8. Data Needs in Opioid Systems Modeling: Challenges and Future Directions. Am J Prev Med. 2021 02; 60(2):e95-e105. Jalali MS, Ewing E, Bannister CB, Glos L, Eggers S, Lim TY, Stringfellow E, Stafford CA, Pacula RL, Jalal H, Kazemi-Tabriz R. PMID: 33272714.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    9. The need to more effectively regulate END markets: A primary public health lesson of the U.S. vaping associated lung injury outbreak. Addiction. 2021 05; 116(5):994-995. Pacula RL. PMID: 32754924.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    10. The state of the science in opioid policy research. Drug Alcohol Depend. 2020 09 01; 214:108137. Schuler MS, Heins SE, Smart R, Griffin BA, Powell D, Stuart EA, Pardo B, Smucker S, Patrick SW, Pacula RL, Stein BD. PMID: 32652376.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    11. How increasing medical access to opioids contributes to the opioid epidemic: Evidence from Medicare Part D. J Health Econ. 2020 05; 71:102286. Powell D, Pacula RL, Taylor E. PMID: 32193022.
      View in: PubMed   Mentions: 4     Fields:    
    12. Early evidence of the impact of cannabis legalization on cannabis use, cannabis use disorder, and the use of other substances: Findings from state policy evaluations. Am J Drug Alcohol Abuse. 2019; 45(6):644-663. Smart R, Pacula RL. PMID: 31603710.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    13. State-Level Approaches to Expanding Pharmacists' Authority to Dispense Naloxone May Affect Accessibility-Reply. JAMA Intern Med. 2019 10 01; 179(10):1443. Abouk R, Pacula RL, Powell D. PMID: 31589265.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. The impacts of potency, warning messages, and price on preferences for Cannabis flower products. Int J Drug Policy. 2019 12; 74:1-10. Shi Y, Cao Y, Shang C, Pacula RL. PMID: 31382201.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    15. Association Between State Laws Facilitating Pharmacy Distribution of Naloxone and Risk of Fatal Overdose. JAMA Intern Med. 2019 06 01; 179(6):805-811. Abouk R, Pacula RL, Powell D. PMID: 31058922.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    16. Abuse-Deterrent Opioids: The Authors Reply. Health Aff (Millwood). 2019 04; 38(4):696. Powell D, Alpert A, Pacula RL. PMID: 30933583.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Prevalence of Cannabis Use in Youths After Legalization in Washington State. JAMA Pediatr. 2019 02 01; 173(2):192-193. Dilley JA, Richardson SM, Kilmer B, Pacula RL, Segawa MB, Cerdá M. PMID: 30566196.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    18. A Transitioning Epidemic: How The Opioid Crisis Is Driving The Rise In Hepatitis C. Health Aff (Millwood). 2019 02; 38(2):287-294. Powell D, Alpert A, Pacula RL. PMID: 30715966.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCellsPHPublic Health
    19. Supply-Side Drug Policy in the Presence of Substitutes: Evidence from the Introduction of Abuse-Deterrent Opioids. Am Econ J Econ Policy. 2018 Nov; 10(4):1-35. Alpert A, Powell D, Pacula RL. PMID: 34326924.
      View in: PubMed   Mentions:
    20. A population-based examination of trends and disparities in medication treatment for opioid use disorders among Medicaid enrollees. Subst Abus. 2018; 39(4):419-425. Stein BD, Dick AW, Sorbero M, Gordon AJ, Burns RM, Leslie DL, Pacula RL. PMID: 29932847.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    21. Cannabis and the Opioid Crisis. Cannabis Cannabinoid Res. 2018; 3(1):108-116. Piomelli D, Weiss S, Boyd G, Pacula RL, Cooper Z. PMID: 29789812.
      View in: PubMed   Mentions:
    22. Medical marijuana laws and adolescent marijuana use in the United States: a systematic review and meta-analysis. Addiction. 2018 06; 113(6):1003-1016. Sarvet AL, Wall MM, Fink DS, Greene E, Le A, Boustead AE, Pacula RL, Keyes KM, Cerdá M, Galea S, Hasin DS. PMID: 29468763.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    23. Do medical marijuana laws reduce addictions and deaths related to pain killers? J Health Econ. 2018 03; 58:29-42. Powell D, Pacula RL, Jacobson M. PMID: 29408153.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    24. Marijuana buyers in the United States, 2010-2014. Drug Alcohol Depend. 2018 02 01; 183:34-42. Azofeifa A, Sherman LJ, Mattson ME, Pacula RL. PMID: 29223915.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    25. Mapping medical marijuana: state laws regulating patients, product safety, supply chains and dispensaries, 2017. Addiction. 2017 Dec; 112(12):2206-2216. Klieger SB, Gutman A, Allen L, Pacula RL, Ibrahim JK, Burris S. PMID: 28696583.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansPHPublic Health
    26. Did the dependent coverage expansion increase risky substance use among young adults? Drug Alcohol Depend. 2017 09 01; 178:556-561. Breslau J, Yu H, Han B, Pacula RL, Burns RM, Stein BD. PMID: 28732319.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    27. Early Impacts of Marijuana Legalization: An Evaluation of Prices in Colorado and Washington. J Prim Prev. 2017 Jun; 38(3):221-248. Hunt P, Pacula RL. PMID: 28456861.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    28. Medical Marijuana and Marijuana Legalization. Annu Rev Clin Psychol. 2017 05 08; 13:397-419. Pacula RL, Smart R. PMID: 28482686.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    29. Building the data infrastructure to evaluate cannabis legalization. Addiction. 2017 07; 112(7):1140-1141. Kilmer B, Pacula RL. PMID: 28477353.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    30. Advancing knowledge on cannabis policy using evidence from North America. Int J Drug Policy. 2017 04; 42:36-38. Stevens A, Pacula RL. PMID: 28314644.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    31. Association of State Recreational Marijuana Laws With Adolescent Marijuana Use. JAMA Pediatr. 2017 02 01; 171(2):142-149. Cerdá M, Wall M, Feng T, Keyes KM, Sarvet A, Schulenberg J, O'Malley PM, Pacula RL, Galea S, Hasin DS. PMID: 28027345.
      View in: PubMed   Mentions: 72     Fields:    Translation:Humans
    32. Preventing, Identifying, and Treating Prescription Drug Misuse Among Active-Duty Service Members. Rand Health Q. 2017 Jan; 7(1):8. Pacula RL, Hunter SB, Ober AJ, Osilla KC, Vardavas R, Blanchard JC, DeVries D, Drabo EF, Leuschner KJ, Stewart W, Walters J. PMID: 29057158.
      View in: PubMed   Mentions:
    33. Understanding and learning from the diversification of cannabis supply laws. Addiction. 2017 Jul; 112(7):1128-1135. Kilmer B, Pacula RL. PMID: 27891693.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    34. Physician Capacity to Treat Opioid Use Disorder With Buprenorphine-Assisted Treatment. JAMA. 2016 Sep 20; 316(11):1211-1212. Stein BD, Sorbero M, Dick AW, Pacula RL, Burns RM, Gordon AJ. PMID: 27654608.
      View in: PubMed   Mentions: 28     Fields:    
    35. A Systematic Review of the Prevention and Treatment of Prescription Drug Misuse. Mil Med. 2016 05; 181(5):410-23. Blanchard J, Hunter SB, Osilla KC, Stewart W, Walters J, Pacula RL. PMID: 27136647.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    36. In the weeds: a baseline view of cannabis use among legalizing states and their neighbours. Addiction. 2016 06; 111(6):973-80. Pacula RL, Jacobson M, Maksabedian EJ. PMID: 26687431.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    37. Policies related to opioid agonist therapy for opioid use disorders: The evolution of state policies from 2004 to 2013. Subst Abus. 2016; 37(1):63-9. Burns RM, Pacula RL, Bauhoff S, Gordon AJ, Hendrikson H, Leslie DL, Stein BD. PMID: 26566761.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    38. Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties. Milbank Q. 2015 Sep; 93(3):561-83. Stein BD, Pacula RL, Gordon AJ, Burns RM, Leslie DL, Sorbero MJ, Bauhoff S, Mandell TW, Dick AW. PMID: 26350930.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    39. Medical marijuana laws and adolescent marijuana use in the USA from 1991 to 2014: results from annual, repeated cross-sectional surveys. Lancet Psychiatry. 2015 Jul; 2(7):601-8. Hasin DS, Wall M, Keyes KM, Cerdá M, Schulenberg J, O'Malley PM, Galea S, Pacula R, Feng T. PMID: 26303557.
      View in: PubMed   Mentions: 88     Fields:    Translation:Humans
    40. Growth In Buprenorphine Waivers For Physicians Increased Potential Access To Opioid Agonist Treatment, 2002-11. Health Aff (Millwood). 2015 Jun; 34(6):1028-34. Dick AW, Pacula RL, Gordon AJ, Sorbero M, Burns RM, Leslie D, Stein BD. PMID: 26056209.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    41. The price elasticity of demand for heroin: Matched longitudinal and experimental evidence. J Health Econ. 2015 May; 41:59-71. Olmstead TA, Alessi SM, Kline B, Pacula RL, Petry NM. PMID: 25702687.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    42. Assessing the effects of medical marijuana laws on marijuana use: the devil is in the details. J Policy Anal Manage. 2015; 34(1):7-31. Pacula RL, Powell D, Heaton P, Sevigny EL. PMID: 25558490.
      View in: PubMed   Mentions: 80     Fields:    Translation:HumansAnimals
    43. More choice in health insurance marketplaces may reduce the value of the subsidies available to low-income enrollees. Health Aff (Millwood). 2015 Jan; 34(1):104-10. Taylor EA, Saltzman E, Bauhoff S, Pacula RL, Eibner C. PMID: 25561650.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    44. Words Can Be Deceiving: A Review of Variation Among Legally Effective Medical Marijuana Laws in the United States. J Drug Policy Anal. 2014 Dec; 7(1):1-19. Pacula RL, Hunt P, Boustead A. PMID: 25657828.
      View in: PubMed   Mentions:
    45. Supply of buprenorphine waivered physicians: the influence of state policies. J Subst Abuse Treat. 2015 Jan; 48(1):104-11. Stein BD, Gordon AJ, Dick AW, Burns RM, Pacula RL, Farmer CM, Leslie DL, Sorbero M. PMID: 25218919.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    46. Developing public health regulations for marijuana: lessons from alcohol and tobacco. Am J Public Health. 2014 Jun; 104(6):1021-8. Pacula RL, Kilmer B, Wagenaar AC, Chaloupka FJ, Caulkins JP. PMID: 24825201.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansPHPublic Health
    47. The effects of medical marijuana laws on potency. Int J Drug Policy. 2014 Mar; 25(2):308-19. Sevigny EL, Pacula RL, Heaton P. PMID: 24502887.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    48. Why Changes in Price Matter When Thinking About Marijuana Policy: A Review of the Literature on the Elasticity of Demand. Public Health Rev. 2014; 35(2):1-18. Pacula RL, Lundberg R. PMID: 25642015.
      View in: PubMed   Mentions: 14     Fields:    
    49. Marijuana liberalization policies: why we can’t learn much from policy still in motion. J Policy Anal Manage. 2014; 33(1):212-21. Pacula RL, Sevigny EL. PMID: 24358530.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    50. Natural experiments in a complex and dynamic environment: the need for a measured assessment of the evidence. J Policy Anal Manage. 2014; 33(1):232-5. Pacula RL, Sevigny EL. PMID: 24358531.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    51. Decomposing Racial Disparities in Prison and Drug Treatment Commitments for Criminal Offenders in California. J Legal Stud. 2014 Jan 01; 43(1):155-187. MacDonald J, Arkes J, Nicosia N, Pacula RL. PMID: 25382877.
      View in: PubMed   Mentions:
    52. Tackling Problem Drug Use. Rand Health Q. 2012; 1(4):9. Cave J, Hunt P, Ismail S, Levitt R, Pacula RL, Rabinovich L, Rubin J, Weed K, Kilmer B. PMID: 28083216.
      View in: PubMed   Mentions:
    53. The U.S. Drug Policy Landscape: Insights and Opportunities for Improving the View. Rand Health Q. 2012; 2(3):2. Kilmer B, Caulkins JP, Pacula RL, Reuter PH. PMID: 28083261.
      View in: PubMed   Mentions:
    54. An Epidemiological Model for Examining Marijuana Use over the Life Course. Epidemiol Res Int. 2012; 2012. Paddock SM, Kilmer B, Caulkins JP, Booth MJ, Pacula RL. PMID: 23236590.
      View in: PubMed   Mentions:
    55. Response to commentaries. Addiction. 2012 May; 107(5):876-7. Caulkins JP, Kilmer B, Maccoun RJ, Pacula RL, Reuter P. PMID: 22471568.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    56. Bringing perspective to illicit markets: estimating the size of the U.S. marijuana market. Drug Alcohol Depend. 2011 Dec 01; 119(1-2):153-60. Kilmer B, Caulkins J, Pacula R, Reuter P. PMID: 22148148.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    57. Design considerations for legalizing cannabis: lessons inspired by analysis of California's Proposition 19. Addiction. 2012 May; 107(5):865-71. Caulkins JP, Kilmer B, MacCoun RJ, Pacula RL, Reuter P. PMID: 21985069.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimals
    58. Substance use and recessions: what can be learned from economic analyses of alcohol? Int J Drug Policy. 2011 Sep; 22(5):326-34. Pacula RL. PMID: 21855312.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    59. Addiction research centres and the nurturing of creativity. RAND's Drug Policy Research Center. Addiction. 2011 Feb; 106(2):253-9. Reuter P, Pacula RL, Caulkins JP. PMID: 20626722.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    60. An Analysis of Applicants Presenting to a Medical Marijuana Specialty Practice in California. J Drug Policy Anal. 2011 Feb; 4(1). Nunberg H, Kilmer B, Pacula RL, Burgdorf J. PMID: 23750291.
      View in: PubMed   Mentions:
    61. Heterogeneity in the composition of marijuana seized in California. Drug Alcohol Depend. 2011 Aug 01; 117(1):59-61. Burgdorf JR, Kilmer B, Pacula RL. PMID: 21288662.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimals
    62. Marijuana use and high school dropout: the influence of unobservables. Health Econ. 2010 Nov; 19(11):1281-99. McCaffrey DF, Pacula RL, Han B, Ellickson P. PMID: 19937639.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    63. RISKS AND PRICES: THE ROLE OF USER SANCTIONS IN MARIJUANA MARKETS. B E J Econom Anal Policy. 2010 Feb 17; 10(1). Pacula RL, Kilmer B, Grossman M, Chaloupka FJ. PMID: 23536916.
      View in: PubMed   Mentions:
    64. The incremental inpatient costs associated with marijuana comorbidity. Drug Alcohol Depend. 2008 Jan 01; 92(1-3):248-57. Pacula RL, Ringel J, Dobkin C, Truong K. PMID: 17928166.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    65. Is the drug court model exportable? The cost-effectiveness of a driving-under-the-influence court. J Subst Abuse Treat. 2006 Jul; 31(1):75-85. Eibner C, Morral AR, Pacula RL, MacDonald J. PMID: 16814013.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    66. Racial differences in marijuana-users' risk of arrest in the United States. Drug Alcohol Depend. 2006 Oct 01; 84(3):264-72. Ramchand R, Pacula RL, Iguchi MY. PMID: 16600529.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    67. Limits of current economic analyses of the demand for illicit drugs. Subst Use Misuse. 2006; 41(4):607-9. Williams J, Pacula RL, Chaloupka FJ, Wechsler H. PMID: 16522567.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    68. College students' use of cocaine. Subst Use Misuse. 2006; 41(4):489-509. Williams J, Pacula RL, Chaloupka FJ, Wechsler H. PMID: 16522560.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    69. What does it mean to decriminalize marijuana? A cross-national empirical examination. Adv Health Econ Health Serv Res. 2005; 16:347-69. Pacula RL, MacCoun R, Reuter P, Chriqui J, Kilmer B, Harris K, Paoli L, Schäfer C. PMID: 17867248.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    70. What we can--and cannot--expect from school-based drug prevention. Drug Alcohol Rev. 2004 Mar; 23(1):79-87. Caulkins JP, Pacula RL, Paddock S, Chiesa J. PMID: 14965889.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    71. State medical marijuana laws: understanding the laws and their limitations. J Public Health Policy. 2002; 23(4):413-39. Pacula RL, Chriqui JF, Reichmann DA, Terry-McElrath YM. PMID: 12532682.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimals
    72. The effects of macro-level interventions on addictive behavior. Subst Use Misuse. 2001 Dec; 36(13):1901-22. Pacula RL, Chaloupka FJ. PMID: 11795584.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    73. Does the sunset of mental health parity really matter? Adm Policy Ment Health. 2001 May; 28(5):353-69. Gitterman DP, Sturm R, Pacula RL, Scheffler RM. PMID: 11678068.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    74. Private insurance: what has parity brought. Behav Healthc Tomorrow. 2001 Apr; 10(2):SR26-8. Sturm R, Pacula RL. PMID: 12741050.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    75. Economics of youth drug use, addiction and gateway effects. Addiction. 2001 Jan; 96(1):151-64. Kenkel D, Mathios AD, Pacula RL. PMID: 11177526.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    76. Datapoints: mental health parity and employer-sponsored health insurance in 1999-2000: II. Copayments and coinsurance. Psychiatr Serv. 2000 Dec; 51(12):1487. Pacula RL, Sturm R. PMID: 11097639.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    77. Mental health parity and employer-sponsored health insurance in 1999-2000: I. limits. Psychiatr Serv. 2000 Nov; 51(11):1361. Sturm R, Pacula RL. PMID: 11058178.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    78. Mental health parity legislation: much ado about nothing? Health Serv Res. 2000 Apr; 35(1 Pt 2):263-75. Pacula RL, Sturm R. PMID: 10778814.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    79. Datapoints: labor force participation by persons with mental illness. Psychiatr Serv. 1999 Nov; 50(11):1407. Sturm R, Gresenz CR, Pacula RL, Wells KB. PMID: 10543847.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    80. State mental health parity laws: cause or consequence of differences in use? Health Aff (Millwood). 1999 Sep-Oct; 18(5):182-92. Sturm R, Pacula RL. PMID: 10495606.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    81. Sex and race differences in young people's responsiveness to price and tobacco control policies. Tob Control. 1999; 8(4):373-7. Chaloupka FJ, Pacula RL. PMID: 10629242.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    82. Does increasing the beer tax reduce marijuana consumption? J Health Econ. 1998 Oct; 17(5):557-85. Pacula RL. PMID: 10185512.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    83. Economic modelling of the gateway effect. Health Econ. 1997 Sep-Oct; 6(5):521-4. Pacula RL. PMID: 9353655.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    Rosalie's Networks
    Concepts (224)
    Derived automatically from this person's publications.
    Co-Authors (3)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department